BG
PFE icon

Berry Group’s Pfizer PFE Stock Holding History

Berry Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.44M Sell
39,153
-1,204
-3% -$44.2K 0.65% 34
2020
Q3 		$1.41M Buy
40,357
+2,335
+6% +$81.9K 0.75% 30
2020
Q2 		$1.18M Buy
38,022
+16
+0% +$544 0.73% 32
2020
Q1 		$1.18M Sell
38,006
-15,277
-29% -$521K 0.89% 30
2019
Q4 		$1.98M Buy
+53,283
New +$1.9M 1.07% 27

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Berry Group's PFE Position: Q4 2020 in Review

Berry Group reduced its Pfizer (PFE) stake by 3% in Q4 2020, selling an estimated $44.2K and leaving 39,153 shares worth $1.44M. The position accounts for 0.65% of the portfolio, ranked #34.

Berry Group first reported a position in PFE in Q4 2019 and has held it in 5 quarters since. The position peaked at $1.98M in Q4 2019. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

  • Berry Group held 39,153 shares of Pfizer worth $1.44M as of Q4 2020.
  • Berry Group sold 1,204 Pfizer shares in Q4 2020, an estimated $44.2K.
  • Pfizer made up 0.65% of Berry Group's portfolio in Q4 2020, its #34 holding.
  • Berry Group first reported a position in Pfizer in Q4 2019 and has held it in 5 quarters since.
  • Berry Group's Pfizer position peaked at $1.98M in Q4 2019.
  • 2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Berry Group's 13F filing for Q4 2020, filed 11 Feb 2021.